Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507117 · ClinicalTrials.gov registry record · Phase 4
Ezopiclone Improves the Quality of Overnight Polysomnography
A Phase 4 study, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT00507117 is a Phase 4 study that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 300 participants.
The verdict
NCT00507117, a Phase 4 study, has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
Patients often have difficulty sleeping during overnight sleep testing in a lab environment. The purpose of this study is to determine if taking a sleep aid will improve sleep and therefore the quality of the sleep study.
Interventions
- DRUG Placebo control
- DRUG Lunesta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507117
The ClinicalTrials.gov registry entry for NCT00507117 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo control is the first listed.
NCT00507117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00507117 about?
NCT00507117 is a clinical study titled "Ezopiclone Improves the Quality of Overnight Polysomnography". Patients often have difficulty sleeping during overnight sleep testing in a lab environment. The purpose of this study is to determine if taking a sleep aid will improve sleep and therefore the quality of the sleep study.
What is the current status of trial NCT00507117?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2007-03. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00507117?
The interventions under investigation include: Placebo control (DRUG), Lunesta (DRUG).
Who is sponsoring clinical trial NCT00507117?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.